We examined the selective effects of interleukin (IL-5) in regulating the maturational expression of surface adhesion molecules on human eosinophils and adhesion t o endothelial cells during eosinophilopoiesis in vitro. Expression of the p2 integrins (CDll/CD18) and the p, integrin,VLA-4 (CD49d/ CD29). was assessed during development in culture with IL-3, IL-5, and granulocyte-macrophage colony stimulating factor in cultures of human umbilical cord blood-derived eosinophil (CDE) precursor cells. Expression of both CD1 l b and CD18 subunits of Mac-1 was lower on CDE which were continuously (=chronically) exposed t o IL-5 than on CDE which were cultured without IL-5 for the final week of culture. (1) increased production of eosinophils in the bone marrow (BM), (2) increased release of eosinophils into the circulation, and (3) selective accumulation of eosinophils in the conducting airways. However, the mechanism(s) that regulate eosinophilopoiesis and the subsequent maturation of adhesion molecules on these cells are not completely understood. Prior investigations have suggested that interleukin-5 (IL-5) plays an important role both in eosinophil development' and in selective adhesion of eosinophils to vascular endothelium during transmigration into the conducting airw a y~.~~' Although some studies have suggested that IL-5 augments the stimulated secretion of bronchoactive substances in human eosinophil^:^ others have suggested that chronic exposure to this cytokine may attenuate functional responses of eosinophils, such as adhesion and
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HE PATHOGENESIS of eosinophilic inflammation in
T human asthma involves several critical steps including (1) increased production of eosinophils in the bone marrow (BM), (2) increased release of eosinophils into the circulation, and (3) selective accumulation of eosinophils in the conducting airways. However, the mechanism(s) that regulate eosinophilopoiesis and the subsequent maturation of adhesion molecules on these cells are not completely understood. Prior investigations have suggested that interleukin-5 (IL-5) plays an important role both in eosinophil development' and in selective adhesion of eosinophils to vascular endothelium during transmigration into the conducting airw a y~.~~' Although some studies have suggested that IL-5 augments the stimulated secretion of bronchoactive substances in human eosinophil^:^ others have suggested that chronic exposure to this cytokine may attenuate functional responses of eosinophils, such as adhesion and
The eosinophilopoietic cytokines, granulocyte-macrophage colony stimulating factor (GM-CSF), IL-3, and IL-5, which regulate eosinophil production in vivo, also enhance isolated peripheral blood (PB) eosinophil function. and promote eosinophil survival and mediator release in vitro.'-" However, little is known about the effects during eosinophilopoiesis of these cytokines on phenotypic expression of surface adhesion molecules or the subsequent adhesive interactions of matured eosinophils with endothelial cells.
Using an in vitro model of eosinophil development," we examined the regulatory role of the cytokines, GM-CSF, IL-3, and IL-5, on the expression and function during maturation of the important eosinophil surface adhesion molecules, the p2 integrins, (CDll/CD18), and the a4pl integrin, VLA-4 (CD49dCD29). Our data show that continuous exposure to IL-5 during in vitro eosinophilopoiesis causes (1) decreased Mac-1 surface expression; ( 2 ) refractoriness of cultured eosinophils to IL-5 -induced upregulation of Mac-la surface expression and adhesion; and (3) enhanced usage of CD49d (compared to CDI 8) during adhesion to resting or stimulated endothelial cells.
MATERIALS AND METHODS
Human umbilical cord blood was collected as previously described" following normal deliveries of newborn infants according to a protocol approved by the University of Chicago Institutional Review Board. The mononuclear cell (MNC) fraction was isolated as follows.'2 Briefly, phosphate-buffered saline (PBS)-diluted (1 :2) cord blood was layered onto one-third volume of HistoPaque-1077 (Sigma Chemical Co, St Louis, MO) and centrifuged at 400g for 30 minutes, The interface, containing the MNC fraction was transferred to a sterile conical tube and washed twice with fresh HL-I medium (Hycor, Inc, Irvine, CA). Cells were counted on a hemacytometer using trypan blue as an indicator of viability and cultured in T-25 flasks (Falcon, Oxnard, CA). Cells were cultured in HL-1 medium containing 5 X lo-" mom IL-3 and 2 x lo-'" mol& IL-5, 10% heatinactivated fetal calf serum (FCS: Hyclone Laboratories, Logan, UT), SO mmoK 2-mercaptoethanol, 2 m m o K L-glutamine, 100 U/ mL penicillin, 100 p g h L streptomycin, and 25 pg/mL gentamicin at 37°C in 5% COz -95% air. Half of the medium containing IL-3 and IL-5 and appropriate supplements were replaced at week 1. At 2 weeks, when 85% to 90% of the cells exhibited eosinophilic granular staining with Wright-Giemsa, cells were washed twice in fresh HL-I medium and each culture was split in half. One half was cultured for an additional week in medium supplemented with 5 x IO-" molL GM-CSF only (without IL-5) whereas the other half was cultured with 5 X IO-'' molL GM-CSF + 2 X IO-" molL IL-5 (= IL-5 -cultured or chronically exposed cord blood-derived eosinophils [CDE] ). Prepared slides were fixed and stained with WrightGiemsa and 2 2 0 0 cells were counted for each preparation and condition: cell types were expressed as percentages of total cells. Cultures that showed signs on bacterial or fungal contamination during an experiment were omitted from the study. This method of in vitro eosinophil differentiation consistently led to highly purified (296%) population of fully granulated, metamyelocyte or more mature stage eosinophils by week 3 in both types of cultures, and cell maturity did not significantly differ between the two types of cultures. Viability exceeded 98% in all cultures. Granule protein analyses, as previously described," showed comparable amounts of major basic protein and eosinophil peroxidase (EPO) in CDE and human PB eosinophils.
Immunofluorescent labeling of cells was performed as previously described." Briefly, after 2 washes, 5 X lo5 cells were suspended in 100 pL cold PBS containing 0.1% bovine serum albumin and 0.01% sodium azide (flow buffer), and Fc receptors were blocked with IO I.c.L of 5% human serum.
Saturating amounts of the primary monoclonal antibodies Endothelial cell isolation and culture. Human umbilical vein endothelial cells (HUVEC) were isolated by collagenase treatment of umbilical veins and passaged as previously described.l4.l5 Briefly, the cells were passaged in 25 cm' gelatin-coated tissue culture flasks in MI99 medium supplemented with 20% FCS, 200 mmol/L Lglutamine, 100 U/mL penicillin, 100 pg/mL streptomycin, and 100 pg/mL heparin, and 50 pg/mL endothelial cell growth factor (Chemicon, Temecula, CA). Second or third passage HUVEC were procured with 0.05% trypsin and 0.02% EDTA in Hanks' balanced salt solution (HBSS). Harvested cells were washed in supplemented MI99 medium and resuspended at 7.5 X lo4 cells/mL, after which they were plated in wells of 96-well microplates (200 pL/well). Confluent monolayers formed within 36 hours of plating, and the cells were used in adhesion assays when confluent. Endothelial cell identity
Flow cytometric analysis.
was confirmed by characteristic morphologic appearance and by positive staining with MoAb against Factor VIlI.
Before adhesion assays, HUVEC monolayers were washed once with HBSS supplemented with 2% FCS (HBSWFCS) and then overlayered with tissue culture medium supplemented with 10 U/mL IL-I for 4 hours or with 1,000 U/mL IL-4 for 24 hours. These concentrations and incubation times were determined in preliminary experiments and from published rep o r t~" . '~ to be optimal activation protocols for HUVEC under the in vitro conditions described.
CDE obtained from single, initial cultures were treated identically for all adhesion assays in side-by-side experiments ( 2 IL-5 exposure during the final week of culture) using the same HUVEC isolates for each population. In some experiments, CDE were preincubated (30 minutes, 37°C) in Dulbecco's PBS (DPBS) containing 5 mmol/ L glucose, 1 mmol/L CaClz, and 1 mmol/L MgC12 (DPBS) alone or DPBS containing IO-' mol/L platelet-activating factor (PAF) or IO-'' mol/L IL-5 as activators ( = acute stimulation)" before washing and adding CDE to HUVEC monolayers. For antibody blockade studies, CDE were incubated in DPBS supplemented with saturating amounts (25 pg/mL) of specific MoAb or isotype-matched binding or nonbinding control antibodies or DPBS alone; antibodies were present throughout the adhesion experiment. CDE (5.0 X IO'/well) were incubated on HUVEC monolayers at 37°C for 30 minutes. Buffer then was aspirated from each test well, each well was washed twice with HBSS/FCS to remove nonadherent CDE, and SO pL of fresh HBSSFCS was added to each well. Separate standard curves for each of the culture types were generated simultaneously by adding known numbers (0 to 5.0 X 104/well) of the appropriate CDE in SO pL HBSSFCS to HUVEC-coated microplate wells. Standards were also incubated at 37°C for 30 minutes and plates then were centrifuged at 35Og for 5 minutes. The supernatant was aspirated carefully and replaced with SO p L of fresh HBSSIFCS. EPO released into the buffer during the incubation with the endothelial cells therefore was removed from both the test wells and the standards. Only cell-associated EPO was present in the microplate wells at the time of assay. All wells were assayed in at least triplicates.
y of EPO was performed as previously described.Ix ' '
This quantitative assay uses measurement of the reaction velocity for the EPO-mediated oxidation of ortho-phenylinediamine (OPD) to determine the quantity of EPO as a marker of eosinophil number. Briefly, for each assay, 7.5 pL of substrate (6 mmol/L OPD in 100 mmollL tris(hydroxymethy1)-aminomethane-HCI buffer, pH 8.0) containing 0.1% Triton X-100 (Sigma), was added to each test and standard well. The microplate was then placed immediately into a thermoregulating microplate absorbance spectrophotometer (Thermomax, Molecular Devices, Menlo Park, CA) at 37°C. Maximal reaction velocity for each well was calculated by interpolation using customized software (Softmax v2.01, Molecular Devices) on a Macintosh computer (Apple Computer, Cupertino, CA) and expressed as mOD/min. The number of adherent CDE present in each test well then were calculated from the separate standard curves (fitted by linear regression) for each of the CDE culture types.
IL-5 was a kind gift from Drs P. Trotta and T.L. Nagabhushan (Schering-Plough Corp, Bloomfield, NJ). IL-3 and GM-CSF were generously supplied by Drs Elaine Thomas and Michael Widmer (Immunex Research and Development Corp, Seattle, WA). IL-la and IL-4 were purchased from Genzyme 
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Cyrokirzes and antibodies.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From and binding isotypic control antibody (anti-CD45, clone J.33) were purchased from Immunotech, Inc (Westbrook, ME). In published reports'.'" and in our preliminary experiments, blockade of adhesion to endothelial cells by anti-CD18 and anti-CDI 1 b were equivalent, but the use of the anti-CD18 MoAb, R15.7, for blockade was more reproducible. Furthermore, neither CDI la nor CDI IC expression on CDE were affected by acute stimulation or differentially affected by the presence or absence of IL-5 during the final week of culture; finally, anti-CDI la and anti-CD1 IC MoAbs were ineffective in blocking adhesion in our preliminary studies. Therefore, to distinguish between a,-mediated and p2-(principally Mac-I-) mediated adhesion, anti-CDI 8 MoAb and anti-CD49d were used to examine the participation of these integrin subunits in CDE adhesion to HU-VEC monolayers. A nonbinding isotypic control MoAb also used in adhesion experiments, OKT3, was a generous gift of Dr Jon Richards (University of Chicago). Other reagents were purchased from Sigma Chemical Co unless otherwise noted.
Data are expressed as the mean 2 one standard error (SE) for each group. Paired sets of data were compared by paired Student's r-test. Comparisons of multiple treatment groups were made by repeated measures analysis of variance (ANOVA). When significant differences were found, additional comparisons were made with Fisher's protected least significant difference test.
Statistical significance was claimed when P < .05. v control for both, n = 4) ( Table I) . Expression of both VLA-4 subunits decreased as CDE matured during the final week of culture. However, unlike Mac-1 expression, baseline expression of CD49d and CD29 was similar for both types of cells at three weeks (P = NS, n = 4 ) ( Table 1) (Fig 2) . By contrast, on CDE cultured in GM-CSF and IL-5 for the final week of culture, the basal level of CDI Ib expression was significantly less (52.5 ?
4.48 MSF P < .Ol), and these cells were refractory to acute IL-5 stimulation of CDI Ib (for all concentrations of IL-5 tested up to 5 x molk). These latter CDE (chronically exposed to 2 x IO-" mom IL-5) were still responsive to PAR IO-' molk PAF upregulated CDI I b expression to levels (129 ? 21.9 MSF; P < .05 v baseline) comparable to those for stimulated CDE cultured without IL-5 for the final week of culture (Fig 2) . CD49d (VLA-4a) surface expression was not altered by acute treatment with either IL-5 or PAF on either type of CDE (data not shown, n = 4). Furthermore, increasing the time of exposure ( 5 2 hours) to either IL-5 or PAF also had no effect on surface CD49d expression (data not shown, n = 3). 
RESULTS
Cell growth and differentiation. Culture of isolated umbilical cord blood MNCs in HL-I medium in the presence of IL-3 (5 X IO-'' mom) and IL-5 (2 X IO-" mol/L) resulted in differentiation of 87.2 t 6.1% of the total cells to the eosinophilic myelocyte or later stage of development within 2 weeks. After splitting and continued culture in GM-CSF (5 X IO-" m o m ) or GM-CSF and IL-5 (2 X IO-" mol/ L), both cultures yielded similar numbers and percentages ( 2 9 5 % ) of metamyelocytic or more mature stage eosinophils (P = NS for all comparisons) (Fig I) .
Expression and regulation of integrins on developing CDE. Flow cytometric analyses of VLA-4 and the fiz inte- Adhesion of CDE to unstimulated HUVEC. Augmentation of adhesion of CDE to unstimulated HUVEC paralleled the changes in Mac-la expression caused by PAF or IL-5. The mean basal level of adhesion of 4,736 2 8 18 CDE cultured without IL-5 (=9.14 2 1.56% adhesion) to HUVEC was similar to that for IL-5-cultured CDE (4,310 2 559 cells = 8.62 2 1.12% adhesion) (P = NS; n = 5) (Fig 3) . The adhesion of nonactivated CDE to HUVEC was enhanced significantly (to approximately 30% adhesion) by pretreatment of HUVEC with IL-la (P < .001 for CDE from both culture conditions) (Fig 4) . CDE cultured without IL-5 during the final week responded to both IO-' mol/L PAF and mol/ L IL-5 and exhibited significantly increased adhesion to IL-I-treated HUVEC (P < .01 for both) (Fig 4) . However, adhesion of CDE cultured continuously with IL-5 was again refractory to IL-5 stimulation. In contrast, stimulation with PAF did enhance the adhesion of these ILJ-cultured CDE to IL-la-activated HUVEC (P < .01) (Fig 4) .
Blockade of CDE adhesion to IL-la-activated HUVEC by MoAb also depended on cytokine exposure during maturation. Anti-CD49d caused substantially greater blockade of adhesion of CDE cultured with IL-5 (45.7 2 5.51%) than did anti-CD18 (25.8 2 5.20%; P < .01). By contrast, anti-CD18 blocked adhesion of CDE cultured without IL-5 more effectively than anti-CD49d (54.2 2 6.01% v 34.1 2 4.15%, respectively; P < .02, n = 5) (Fig 5) . The binding isotypic control antibody (anti-CD45) did not inhibit adhesion to ILla-activated HUVEC of CDE cultured with or without IL-5 (4.22 2 5.14% and 6.31 2 5.75%, respectively; P = NS). Similarly, a nonbinding control antibody (OKT3) had no effect on adhesion (-3.45 2 3.81% and 2.51 2 3.91%, respectively; P = NS).
Adhesion of CDE to IL-4-activated HUVEC. Pretreatment of HUVEC with IL-4 augmented adhesion of CDE grown under either culture condition (Fig 6) . Treatment of mol/L) (Fig 3) . Adhesion of CDE to IL-la-Activated HUVEC.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From CDE with IL-5 or PAF, however, did not further augment adhesion of CDE (P = NS, n = 4) (Fig 6) .
Anti-CD49d (-VLA-4a) blocked adhesion of CDE to IL-4-activated HUVEC; HP 2/1 caused 56.8 2 9.83% inhibition (P < .05) of adhesion for CDE cultured without IL-5 and 68.3 2 7.76% blockade (P < .001) for CDE cultured with IL-5 (Fig 7) . However, although anti-CD18 blocked a smaller but significant proportion (28.6 t 6.84%; P < .05 v control) of CDE cultured without IL-5, the adhesion of IL-5-cultured CDE to IL-4-stimulated HUVEC was not blocked significantly by anti-CD18 (7.05 ? 5.71%; P = NS v control). The combination of anti-CD18 and anti-CD49d did not block the adhesion of IL-S-cultured CDE beyond that blocked by anti-CD49d alone (data not shown), and binding isotypic control antibody (anti-CD45) did not inhibit adhesion to IL-4-activated HUVEC of CDE cultured with or without IL-S (5.88 t 6.12% and 2.67 2 3.73%. respec- and for CDE cultured without 11-5 ( P i .05; n = 4). However, although anti-CD18 blocked moderate but significant ( P i .05; n = 4) numbers of CDE cultured without IL-5, this MoAb was ineffective at blocking the adhesion of IL-5-cultured CDE t o these HUVEC ( P = NS vcontrol; n = 41. Binding and nonbinding isotypic control MoAb had no effect on the adhesion of cells from either culture condition to Il-l-activated HUVEC ( P = NS v baseline; n = 41.
tively; P = NS). Similarly, a nonbinding control antibody (OKT3) had no effect on adhesion (1.01 t 3.04% and -1 S 9 2 2.38%, respectively; P = NS).
DISCUSSION
The objective of this investigation was to determine the effects of cytokine exposure during eosinophil development and maturation in vitro on surface expression and function of the 0. integrins, LFA-I, Mac-I , p150,95, and the PI integrin, VLA-4, and on cultured eosinophils. In vivo exposure of eosinophils to eosinophilopoietic cytokines has been implicated in altering the activation status of eosinophils as determined by examination of extracted, isolated peripheral blood eosinophils in vitro."" The point(s) at which eosinophils can be affected by this exposure in vivo, however, is not known, and it has been generally assumed that in vivo activation takes place in the peripheral circulation or at inflammatory sites."." We examined the hypothesis that exposure during development of eosinophils to different cytokines affects expression and subsequent regulation and function of adhesion molecules, specifically the principal functional integrins on these eosinophils, Mac-l (CD1 1 b/CD18) and VLA-4 (CD49dKD29).
Initial studies were performed to determine the expression of the Pz integrins and VLA-4 on eosinophils (CDE) cultured from human umbilical cord blood progenitors. We found that CDE grown for 2 weeks in 1L-3 and IL-5 expressed significant amounts of the subunits of all four integrins. Under the two conditions tested, ie, continued growth in GM-CSF + IL-5 or continued growth in GM-CSF alone, CDE expressed similar amounts of the integrin subunits CD1 la, CD1 IC, CD29, and CD49d. but different amounts of CD1 1 b and CD18. Specifically, CDE grown in the continued presence of IL-5 expressed fewer CD1 Ib (Fig 2) and CD18
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From molecules on their surface. CDE cultured continuously with IL-5 also were refractory to IL-5-stimulated upregulation of CD1 l b expression. Interaction between IL-5 and its receptor could lead to internalization of the cytokine-receptor complexZ3 or conformation-and/or transduction-mediated desensitization of the receptor^,'^ but we have not yet identified the specific mechanism involved in the IL-5 -refractoriness observed in the present studies.
Reduced expression of the p2 subunit (CD18) integrins has been reported for hypodense eosinophils from hypereosinophilic syndrome patients,25 and reduced expression of Mac-1 (aM or CDl l b subunit) (compared to PB eosinophils) was observed on eosinophils cultured from cord blood progenitors in the presence of IL-3 and IL-S? Our results concur with the latter report and further suggest that differences in cytokine exposure during eosinophil development may be important in determining levels of expression of both subunits of Mac-1 as well as subsequent cytokine (IL-5)-mediated regulation of surface expression and activation. The apparent reduction in CD18 during the final week of maturation of CDE may be a phenomenon common in granulocytopoiesis in vitro; a recent study of neutrophil maturation also reported a slight decrease in CD18 expression during the terminal differentiation of neutrophil^.'^ The apparent discrepancy between CD1 l b and CD18 (CD1 l b increase versus CD 18 decrease) may be partly explained by the concurrent decreases in CD1 l a and CD1 IC (see Table 1 ). Furthermore, the dynamics of surface expression of integrins on developing leukocytes are not well understood and may not correlate directly with biosynthesis. The functional significance of stage-dependent expression of integrins is not known but may be related to release or retention of cells in the BM.27 Similarly, VLA-4 levels dropped during the final week of in vitro development of CDE. Progenitor cells strongly express VLA-427.z8 and downregulation of VLA-4 in vivo also may be related to mobilization of maturing cells into the bloodstreamz9
Basal levels of (3-week-old) CDE adhesion to quiescent or IL-1 -activated HUVEC are similar to those reported for PB however, as with surface expression, upregulation of adhesion by acute stimulation with IL-5 was observed only in the CDE cultured in the absence of IL-5 for the last week of culture; CDE cultured in the continued ("chronic") presence of IL-5 were refractory to acute IL-5-induced upregulation of adhesion to these HUVEC ( Figs  3 and 4) . Eosinophil adhesion to IL-4-activated HUVEC was similar for CDE cultured continuously with or in the absence of IL-5 (Fig 6 ) . The ineffectiveness of either IL-5 or PAF stimulation to upregulate further adhesion may be the result of maximal expression and activation (affinity) of VLA-4 on these cultured cells and consequent binding to vascular cell adhesion molecule-1 (VCAM-I), a ligand for VLA-4 that is preferentially upregulated on IL-4-activated HUVEC. '7,3Z Blockade of eosinophil adhesion to endothelial cells has been reported by other investigators using eosinophils from normal subjects17 and mildly allergic or asthmatic patients, 17.26.30. 31 Our results show that, as for PB eosinophils, both anti-CD18 and anti-VLA-4 can at least partially block CDE adhesion to HUVEC. Blockade of CDE adhesion to quiescent HUVEC with anti-VLA-4 has not been previously reported to our knowledge and may be due VLA-4 activation on these cultured cells and VLA-4NCAM-1 interactions. Our preliminary studies of VCAM-1 expression on quiescent HUVEC consistently demonstrated low but statistically significant expression (data not shown, n = 3) as has been shown in other Alternatively, because the anti-VLA-4a MoAb, HP2/1, blocks both VCAM-1 and fibronectin domains of VLA-4,37 VLA-4 on these CDE may bind to fibronectin expressed by HUVEC3S,'R or perhaps other confirmed but undefined endothelial receptors for VLA-4.'" Recently, Weller et a14" showed that both anti-CD18 and anti-VLA-4 blocked adhesion to tumor necrosis factor-astimulated HUVEC by eosinophils obtained from normal and eosinophilic donors. Interestingly, their data suggested that adhesion of eosinophils obtained from eosinophilic donors was blocked more effectively by anti-VLA-4 than by CD18, and the converse was true for "normal" eosinophils. Our results with cultured CDE (Figs 6 and 8) are consistent with these findings and suggest that cytokine exposure during development is an important factor in this phenomenon. Further, they suggest that "chronic" exposure to IL-5 and/ or exposure to excessive amounts of IL-5 may result in an eosinophil phenotype, which "preferentially" uses the VLA-4 (PI) ligand rather than the p2 ligand pathway during adhesion to HUVEC.
It is important to consider the limitations of our findings. Our data are derived from an in vitro model of eosinophilopoiesis, which may not reflect some components of the in vivo production of eosinophils in the BM. Although our data show the production of eosinophils from progenitor cells using IL-3, GM-CSF, and IL-5, the kinetics and levels of exposure to these cytokines in vivo is not known. Nevertheless, all three are widely accepted as "eosinophilopoietic" cytokines, which likely are involved in the in vivo production of human eosinophils.',*' Furthermore, we have shown previously that eosinophils cultured from human umbilical cord blood are morphologically, biochemically, and physiologically similar to PB eosinophils isolated from human blood after maturation in vivo." The extent to which adhesion to cultured HUVEC accurately models eosinophil adhesion to vascular endothelial cells in vivo remains to be established. However, numerous recent studies have provided evidence supporting the operation of both PI (VLA-4) and P2 (Mac-I ) ligands in the migration of eosinophils in vivo41-'3 as is suggested by studies of HUVEC monolayer^.'^ It also should be noted that whereas VLA-4 has been considered the major a 4 integrin on eosinophils, another a4 integrin, a&, has been identified recently on human eosinophils.45 Although a4P7 is an important lymphocyte receptor for MAdCAM-I , its function on eosinophils remains to be elucidated. Nevertheless, on lymphocytes it can act as a receptor for VCAM-1 and f i b r~n e c t i n .~~ Therefore, it should be noted that until additional details of a4 integrin expression and function on human eosinophils are elucidiated, blockade with HP2/1 must be considered a blockade of any a4 integrin-mediated adhesion rather than of VLA-4-mediated binding alone.
We conclude that eosinophils cultured from human umbilFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From ical cord blood progenitor cells express functional Mac-1 and VLA-4 integrins. The expression and functional regulation of at least one of these molecules, Mac-1, are affected by exposure to IL-5 during in vitro development. Continued exposure to IL-5 during in vitro development caused decreased Mac-l expression. Furthermore, subsequent IL-5 regulation of adhesion to endothelial cell monolayers through PI and P2 ligands are directly affected by the nature and duration of IL-5 exposure during eosinophil maturation. Finally, the in vitro growth of CDE may provide a useful system to study cytokine-and stage-dependent adhesion molecule expression and function on developing eosinophils.
